Tag: Fibroids
FDA OKs System for Certain Lap Power Morcellator Procedures
But most women aren't candidates because of cancer risk, agency says
Same-Day Discharge OK for Minimally Invasive Myomectomy
Low readmission rate within 48 hours and no life-threatening events or reoperation
Study Looks at Impact of FDA Safety Alert on Morcellation
Decrease in use of minimally invasive hysterectomy, increase in complications after alert issued
High T, Estradiol Increases Risk of Incident Fibroid Development
Opposite effect seen with high T, estradiol on the risk of recurrent fibroids
Doctors Rally in Support of Morcellator Use Curbed by FDA
Agency overstated odds of power morcellator spreading cancer, review group says
Review: Risk of Parasitic Myoma Post Laparoscopic Morcellation
Overall incidence of parasitic myomas 0.12 to 0.95 percent after laparoscopic morcellation
Many Women Receive Unnecessary Hysterectomies
Alternative treatments for benign indications, such as uterine fibroids, are often underused
